Literature DB >> 413562

T and B lymphocytes in alpha-chain disease.

A Kharazmi, M H Rezai, P Abadi, K Nasr, P Haghighi, M Haghshenas.   

Abstract

The patients studied were diagnosed as suffering from alpha-chain disease by their clinicopathological features, malabsorption findings, X-ray, and presence of abnormal alpha-chain protein in their serum. The objective of the study was to determine any possible defect of the immune system in such patients. The rosette technique and surface immunofluorescence were used to enumerate the circulating T and B lymphocytes in these patients. They were also skin-tested with tuberculin and given sensitizing doses of dinitrochlorobenzene. Their serum immunoglobulins were also quantitated. It was found that the proportion of circulating B lymphocytes was much higher than normal, whereas that of T lymphocytes was lower than normal. Furthermore, they could not be sensitized to DNCB and their skin test to tuberculin was negative. It was concluded that the disease was a B-cell disease of IgA type, associated with low level of cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 413562      PMCID: PMC2009509          DOI: 10.1038/bjc.1978.7

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Isolation of normal T cells in chronic lymphatic leukaemia.

Authors:  J Wybran; S Chantler; H H Fudenberg
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

2.  Alpha-chain disease: a new immunoglobulin abnormality.

Authors:  M Seligmann; F Danon; D Hurez; E Mihaesco; J L Preud'homme
Journal:  Science       Date:  1968-12-20       Impact factor: 47.728

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Clinico-pathological study of a patient with "Mediterranean" type of abdominal lymphoma and a new type of IgA abnormality ("alpha chain disease").

Authors:  J C Rambaud; C Bognel; A Prost; J J Bernier; Y Le Quintrec; A Lambling; F Danon; D Hurez; M Seligmann
Journal:  Digestion       Date:  1968       Impact factor: 3.216

5.  Alpha chain disease.

Authors:  M Seligmann; E Mihaesco; B Frangione
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

6.  Alpha-chain disease and its association with intestinal lymphoma.

Authors:  A Kharazmi; P Haghighi; M Haghshenas; K Nasr; P Abadi; H R Rezai
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

7.  Primary intestinal lymphoma and its relation to alpha heavy chain disease.

Authors:  B Ramot; N Hulu
Journal:  Br J Cancer Suppl       Date:  1975-03

8.  Five cases of alpha chain disease.

Authors:  W F Doe; K Henry; J R Hobbs; F A Jones; C E Dent; C C Booth
Journal:  Gut       Date:  1972-12       Impact factor: 23.059

9.  Primary lymphoma of the upper small intestine.

Authors:  K Nasr; P Haghighi; K Bakhshandeh; M Haghshenas
Journal:  Gut       Date:  1970-08       Impact factor: 23.059

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.